The World Health Organization (WHO) has strengthened its response to liver disease in the European Region with the establishment of a new collaborating centre focused on improving research, prevention and public health action. The initiative aims to support countries in tackling growing challenges linked to liver conditions, including viral hepatitis, metabolic liver disease and other causes of liver-related illness.
The development comes as European health systems face increasing pressure from preventable liver diseases, with experts highlighting the need for earlier diagnosis, better awareness and stronger links between scientific evidence and national healthcare policies. The new WHO collaborating centre will provide technical expertise and support regional efforts to reduce the burden of liver disease.
Why Is The New WHO Collaborating Centre Important For Liver Disease?
The new WHO collaborating centre is significant because it creates a dedicated platform for cooperation between international health authorities, researchers and healthcare professionals working on liver disease. WHO collaborating centres are specialist institutions that support the organisation’s programmes by providing expertise, research capacity, training and technical assistance to Member States.
Liver disease has become an increasingly important public health issue across Europe. Conditions such as viral hepatitis, alcohol-related liver disease and steatotic liver disease are contributing to rising healthcare demands and preventable illness. The new centre is expected to help strengthen evidence-based approaches to prevention, detection and treatment.
The initiative also reflects a wider shift in healthcare policy towards addressing chronic diseases through early intervention and population-level strategies. By bringing together scientific knowledge and public health planning, the centre aims to support countries in developing more effective responses.
What Will The WHO Liver Disease Centre Focus On?
The WHO collaborating centre will focus on strengthening knowledge and action around liver health across the European Region. Key areas are expected to include improving research collaboration, supporting healthcare capacity and helping countries implement effective approaches to diagnosis and disease management.
One major priority is likely to be addressing gaps in early detection. Many liver conditions can develop without obvious symptoms during their early stages, meaning patients may only seek care once serious complications appear. Improving testing pathways and awareness campaigns could help identify cases earlier.
The centre will also contribute to wider efforts to tackle viral hepatitis, which remains a major health challenge. WHO has previously highlighted the importance of expanding testing, improving access to treatment and supporting national elimination strategies for hepatitis B and hepatitis C.
How Does Liver Disease Affect Public Health In Europe?
Liver disease affects millions of people worldwide and represents a growing concern for healthcare systems. In Europe, changing lifestyles, rising levels of obesity and metabolic conditions, alcohol consumption patterns and infectious diseases all contribute to the burden.
Steatotic liver disease, previously often associated with fatty liver conditions, has received increasing attention because of its links with metabolic health problems. Research organisations and health authorities have been working to improve understanding of the condition and develop better prevention methods.
Experts warn that without stronger prevention and early treatment measures, advanced liver disease cases could place additional pressure on hospitals and specialist services. Public health approaches focusing on healthier lifestyles, vaccination, screening and accessible treatment are therefore becoming increasingly important.
What Have Health Experts Said About The Development?
Health experts have emphasised that collaboration between organisations is essential to tackling complex health challenges. WHO’s network of collaborating centres allows specialist institutions to contribute knowledge and practical solutions while helping countries strengthen healthcare systems.
Researchers working in hepatology have also highlighted the importance of translating scientific discoveries into real-world healthcare improvements. Partnerships between global health bodies, universities and medical organisations can help accelerate progress by sharing data, research findings and successful approaches.
The creation of a dedicated liver disease centre demonstrates growing recognition that liver health requires coordinated action across prevention, clinical care and public policy.
How Could The New Centre Improve Patient Care?
The new WHO collaborating centre could improve patient care by helping countries develop stronger healthcare strategies based on research and evidence. Better guidance for healthcare workers, improved training and stronger monitoring systems could support earlier diagnosis and more effective treatment.
Patients could benefit from increased attention to prevention programmes and improved access to specialist services. In particular, people at higher risk of liver disease may gain from more targeted screening and public health interventions.
The centre may also encourage greater cooperation between European countries, allowing successful approaches in one healthcare system to inform improvements elsewhere.
What Is The Background Behind WHO Collaborating Centres?
WHO collaborating centres are part of a global network of specialist institutions that work alongside the organisation to support international health goals. They include research institutes, universities, hospitals and national health organisations with expertise in specific fields.
The network allows WHO to access specialist knowledge while helping Member States receive technical support. There are more than 800 WHO collaborating centres worldwide, supporting work across areas including health research, disease prevention, health information and healthcare development.
Previous WHO collaborations on liver health have included efforts focused on viral hepatitis elimination, including support for countries developing testing and treatment strategies.
What Happens Next For The European Liver Disease Response?
The next stage will involve turning the new collaboration into practical action through research programmes, healthcare support and policy development. The effectiveness of the centre will depend on how successfully its expertise can be translated into improvements for national health systems.
As liver disease continues to challenge healthcare services across Europe, stronger cooperation between scientists, clinicians and policymakers will remain essential. The new WHO collaborating centre represents a further step towards a more coordinated regional response, and its future work will be closely monitored as countries seek to reduce preventable liver-related illness.
